Additionally, impairing the expression of TAK1 in TAB3-overexpressed HCC cells impeded the enhanced NF-кB activity evidenced by dual luciferase reporter assays (Additional file 1: Fig. S3F, G). Here, TAB3 is linked to hepatocellular carcinoma.